National Cancer Institute; Notice of Closed Meetings, 70537-70538 [2014-27937]

Download as PDF mstockstill on DSK4VPTVN1PROD with NOTICES Federal Register / Vol. 79, No. 228 / Wednesday, November 26, 2014 / Notices 28. Girldene Jackson, Philadelphia, Pennsylvania, Court of Federal Claims No: 14–0973V. 29. James Bergeron, Southgate, Michigan, Court of Federal Claims No: 14–0974V. 30. Margaret Bannister, Jefferson City, Missouri, Court of Federal Claims No: 14–0975V. 31. Jennifer Peabody Barr, Franklin, Tennessee, Court of Federal Claims No: 14–0977V. 32. Harvard Davis, Fair Oaks, California, Court of Federal Claims No: 14–0978V. 33. Linda Parker, Palatka, Florida, Court of Federal Claims No: 14–0979V. 34. StellaMarie Liverance, Germantown, Tennessee, Court of Federal Claims No: 14–0980V. 35. Kim Finch, Germantown, Tennessee, Court of Federal Claims No: 14–0981V. 36. Tesha Smith, Dallas, Texas, Court of Federal Claims No: 14–0982V. 37. Virginia Shives, Rockford, Illinois, Court of Federal Claims No: 14–0983V. 38. Gaena Maria Laney, Fayetteville, Arkansas, Court of Federal Claims No: 14–0984V. 39. Vivian Reinard, Doylestown, Pennsylvania, Court of Federal Claims No: 14–0987V. 40. Paula Sims, Yonkers, New York, Court of Federal Claims No: 14–0988V. 41. Tracy Czuprynski, Boston, Massachusetts, Court of Federal Claims No: 14–0990V. 42. Rochelle Beaver, Boston, Massachusetts, Court of Federal Claims No: 14–0991V. 43. Christina Lokay, King of Prussia, Pennsylvania, Court of Federal Claims No: 14–0993V. 44. Monica Chenowith on behalf of A. N., Baraboo, Wisconsin, Court of Federal Claims No: 14–0996V. 45. Shari Buetow, Baraboo, Wisconsin, Court of Federal Claims No: 14–0998V. 46. Krista Kuntzelman and James Kuntzelman on behalf of Emma Kuntzelman, Tampa, Florida, Court of Federal Claims No: 14–0999V. 47. Erin Quackenbush-Baker, Twin Falls, Idaho, Court of Federal Claims No: 14–1000V. 48. Vincent M. Cusimano, New Orleans, Louisiana, Court of Federal Claims No: 14–1003V. 49. Irwin Reich, Hicksville, New York, Court of Federal Claims No: 14– 1004V. 50. Chelsey Atnip, Kaysville, Utah, Court of Federal Claims No: 14–1006V. 51. Nona Jones, Selmer, Tennessee, Court of Federal Claims No: 14–1007V. 52. William Moyer, Middlebrook, Virginia, Court of Federal Claims No: 14–1008V. VerDate Sep<11>2014 17:21 Nov 25, 2014 Jkt 235001 53. Isaac Bord and Elisa Pagano on behalf of Alexander Bord, Rockaway, New York, Court of Federal Claims No: 14–1009V. 54. Elizabeth Schandel, Farmingville, New York, Court of Federal Claims No: 14–1010V. 55. Garry Rehn, Elk River, Minnesota, Court of Federal Claims No: 14–1012V. 56. Catherine Smith, Sault Sainte Marie, Michigan, Court of Federal Claims No: 14–1013V. 57. Ann Marie Plastino on behalf of Alfred Plastino, Chicago, Illinois, Court of Federal Claims No: 14–1014V. 58. Bruce A. Ling, Jr., Bristol, Florida, Court of Federal Claims No: 14–1017V. 59. John Summers, Longview, Washington, Court of Federal Claims No: 14–1018V. 60. Steven T. McGehee, Greensboro, North Carolina, Court of Federal Claims No: 14–1020V. 61. Christopher Purvis, New London, Connecticut, Court of Federal Claims No: 14–1025V. 62. Renee Leetta Hunter, Bowie, Maryland, Court of Federal Claims No: 14–1026V. 63. Reuben Calixto and Sandra Calixto on behalf of D. C., Chicago, Illinois, Court of Federal Claims No: 14– 1029V. 64. Heather Cook, Baraboo, Wisconsin, Court of Federal Claims No: 14–1030V. 65. Hannah Baiona, Marblehead, Massachusetts, Court of Federal Claims No: 14–1032V. 66. Christie Shine, Loma Linda, California, Court of Federal Claims No: 14–1033V. 67. Angela Clark, Shelby, North Carolina, Court of Federal Claims No: 14–1034V. 68. Razene Lewis, Bossier City, Louisiana, Court of Federal Claims No: 14–1035V. 69. David Weber, Mason, Ohio, Court of Federal Claims No: 14–1036V. 70. Barbara Verdick, Dallas, Texas, Court of Federal Claims No: 14–1039V. 71. Roberta Livolsi, Boston, Massachusetts, Court of Federal Claims No: 14–1040V. 72. Christine Haley, Boston, Massachusetts, Court of Federal Claims No: 14–1041V. 73. Richard Florida, Washington, Pennsylvania, Court of Federal Claims No: 14–1044V. 74. Helen Forrest, Jacksonville, Florida, Court of Federal Claims No: 14– 1046V. 75. Connie Graham on behalf of Kaden Stuart, Duncan, Oklahoma, Court of Federal Claims No: 14–1047V. 76. James Greenamyre on behalf of Lacey J. Greenamyre, Middlebury, PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 70537 Vermont, Court of Federal Claims No: 14–1048V. 77. Amy Fogg, Lancaster, New Hampshire, Court of Federal Claims No: 14–1050V. 78. Julie Hallquist, Washington, District of Columbia, Court of Federal Claims No: 14–1052V. 79. Bruce A. Pederson, St. Cloud, Minnesota, Court of Federal Claims No: 14–1055V. 80. Amanda L. Isaacson, Milwaukee, Wisconsin, Court of Federal Claims No: 14–1056V. 81. Gregory Simpson and Sandra Simpson on behalf of H. S., Vienna, Virginia, Court of Federal Claims No: 14–1057V. 82. Sebastion J. Robinson, Ruston, Louisiana, Court of Federal Claims No: 14–1058V. 83. Valerie Dobbins, Greensboro, North Carolina, Court of Federal Claims No: 14–1059V. 84. John Lovelady, Boston, Massachusetts, Court of Federal Claims No: 14–1063V. 85. Marc Cosentino, Boston, Massachusetts, Court of Federal Claims No: 14–1064V. 86. Miranda Werner on behalf of P.M.S., Louisville, Kentucky, Court of Federal Claims No: 14–1065V. [FR Doc. 2014–27987 Filed 11–25–14; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel Quantitative Imaging for Evaluation of Response to Cancer Therapies. Date: January 29–30, 2015. Time: 10:30 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\26NON1.SGM 26NON1 70538 Federal Register / Vol. 79, No. 228 / Wednesday, November 26, 2014 / Notices Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 1E030, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Gerald G. Lovinger, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W266, Bethesda, MD 20892–9750, 240–276–6385, lovingeg@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel Omnibus SEP–17. Date: March 25, 2015. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, 7W124, Rockville, MD 20850 (Telephone Conference Call). Contact Person: David Ransom, Ph.D., Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W124, Bethesda, MD 20892–9750, 240–276–6351 david.ransom@nih.gov. Information is also available on the Institute’s/Center’s home page: http:// deainfo.nci.nih.gov/advisory/sep/sep.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: November 20, 2014. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–27937 Filed 11–25–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health mstockstill on DSK4VPTVN1PROD with NOTICES Center for Scientific Review Amended; Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, November 11, 2014, 02:00 p.m. to November 11, 2014, 03:00 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD, 20892 which was published in the Federal Register on October 16, 2014, 79 FR 200 Pg. 62166. The meeting will be held on December 9, 2014 instead of November 11, 2014. The meeting will start at 12:00 VerDate Sep<11>2014 17:21 Nov 25, 2014 Jkt 235001 p.m. and will end at 2:00 p.m. The meeting location remains the same. The meeting is closed to the public. Dated: November 20, 2014. Carolyn A. Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–27936 Filed 11–25–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY [Docket Number DHS–2013–0052] Environmental Planning and Historic Preservation Program Department of Homeland Security. ACTION: Notice of Final National Environmental Policy Act Implementing Procedures. AGENCY: The purpose of this notice is to inform the public that the Department of Homeland Security (DHS or the Department) is issuing the final update to its policy and procedures for implementing the National Environmental Policy Act of 1969 (NEPA) (42 U.S.C. 4321 et seq.), as amended, and the Council on Environmental Quality (CEQ) regulations for implementing the procedural provisions of NEPA (40 CFR parts 1500–1508). The Department’s NEPA procedures are contained in Directive 023–01, Rev. 01 and Instruction Manual 023–01–001–01, Rev. 01, Implementation of the National Environmental Policy Act (herein after referred to as Directive and Instruction). This notice also responds to the comments received on the Department’s draft updated procedures published on June 5, 2014 (79 FR 32563). DATES: The Directive and Instruction will be effective on March 26, 2015. FOR FURTHER INFORMATION CONTACT: A. Marie Ecton, Senior Environmental Specialist, Department of Homeland Security, Telephone (202) 360–5661, or Email a.marie.ecton@hq.dhs.gov. SUPPLEMENTARY INFORMATION: Once effective, the Directive and Instruction will apply to all of DHS, which is currently comprised of over 20 support and operational components, and help ensure the integration of environmental stewardship into DHS decision making as required by NEPA. The Directive and Instruction will serve as the DHS implementing procedures for NEPA and the CEQ regulations (as required by 40 CFR 1505.1 and 1507.3) and therefore must be read in conjunction with the CEQ regulations. SUMMARY: PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 The Directive and Instruction were substantially revised to address a number of circumstances and requirements that have arisen since April 19, 2006, the effective date of the original DHS NEPA procedures (Federal Register, Vol. 71, No. 64, April 4, 2006). For example, when originally published in 2006 the Directive and Instruction did not apply to the following three Components of DHS: Federal Emergency Management Agency (FEMA), Customs and Border Protection (CBP), and United States Coast Guard (USCG); these three Components each maintained their own procedures for implementing NEPA when the Department was established in 2002. This revision to the Directive and Instruction incorporates FEMA, CBP, and USCG into the Department’s NEPA procedures and addresses the full scope of DHS activities to which NEPA applies. When the updated procedures become effective, they will apply to all Components of DHS, including FEMA, CBP, and USCG. In addition, every Component will have the option of developing Supplemental Instructions to establish how that particular Component will meet the requirements of the final version of the DHS Directive and Instruction. In a separate yet related effort, FEMA will pursue rescission of its regulations at 44 CFR 10 and replace them with Supplemental Instructions that conform to requirements of the DHS Directive and Instruction. The requirements put forth in the revised Directive and Instruction emphasize that the NEPA process must be appropriately integrated into the performance of DHS missions and activities and decision making. The revised Directive establishes the overall policy that DHS will comply with NEPA, and the revised Instruction establishes the procedures for ensuring this compliance is implemented in an effective and efficient manner. The Instruction covers the following: Overview of NEPA requirements, including requirements for the preparation and content of NEPA documents; management of NEPA implementation in DHS; criteria for Components to obtain a delegation of authority to approve their respective NEPA reviews; public involvement; dispute resolution; information protected from public disclosure; procedures for emergencies; review of applications from persons or organizations outside of DHS (e.g., grant applications); and an identification of the types of DHS activities normally reviewed in a CATEX, Environmental E:\FR\FM\26NON1.SGM 26NON1

Agencies

[Federal Register Volume 79, Number 228 (Wednesday, November 26, 2014)]
[Notices]
[Pages 70537-70538]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-27937]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel Quantitative Imaging for Evaluation of Response to Cancer 
Therapies.
    Date: January 29-30, 2015.
    Time: 10:30 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 70538]]

    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 1E030, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Gerald G. Lovinger, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W266, Bethesda, MD 20892-9750, 240-276-6385, 
lovingeg@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel Omnibus SEP-17.
    Date: March 25, 2015.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, 7W124, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: David Ransom, Ph.D., Research Programs Review 
Branch, Division of Extramural Activities, National Cancer 
Institute, NIH, 9609 Medical Center Drive, Room 7W124, Bethesda, MD 
20892-9750, 240-276-6351 david.ransom@nih.gov.
    Information is also available on the Institute's/Center's home 
page: http://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: November 20, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-27937 Filed 11-25-14; 8:45 am]
BILLING CODE 4140-01-P